OBES SURG 27(11):29332939 Noparatayaporn P, Thavorncharoensap M, Chaikledkaew U, Bagepally BS, Thakkinstian A (2021) Incremental net monetary benefit of bariatric surgery: systematic review and meta-analysis of cost-effectiveness evidences
GLP-1 is a hormone the body naturally produces when people eat food to signal fullness to the brain
It communicates with multiple organs, including the brain, pancreas, stomach, and digestive system to help regulate hunger, blood sugar, and energy balance
Extending the half-life has become a key issue in GLP-1-related studies
This level of pain can indicate muscle injury, severe inflammation, or rhabdomyolysis
Novo Nordisk finished January-September 2025 with DKK 95.264 billion ($14.907 billion) for semaglutide in adult type 2 diabetes (marketed as Ozempic ), up only 10% from DKK 86.489 billion ($13.533 billion) in January-September 2024